Environmental Persistent Pharmaceutical Pollutants: Difference between revisions
Jump to navigation
Jump to search
(Added some more links under the "External Links" section) |
(Minor Clarification) |
||
| Line 1: | Line 1: | ||
=Basics= | =Basics= | ||
*A class of [[Contaminants of emerging concern]] | *A class of [[Contaminants of emerging concern]] | ||
*Abbreviated as EPPP(s) | |||
*Essentially Pharmaceutical Precursors, Pharmaceuticals, and Pharmaceutical Metabolites / Waste | *Essentially Pharmaceutical Precursors, Pharmaceuticals, and Pharmaceutical Metabolites / Waste | ||
*Can come from a [[Point Source]] such as a factory, but the main context is in [[Black Water]] by people utilizing Pharmaceuticals | *Can come from a [[Point Source]] such as a factory, but the main context is in [[Black Water]] by people utilizing Pharmaceuticals | ||
Revision as of 17:02, 16 July 2022
Basics
- A class of Contaminants of emerging concern
- Abbreviated as EPPP(s)
- Essentially Pharmaceutical Precursors, Pharmaceuticals, and Pharmaceutical Metabolites / Waste
- Can come from a Point Source such as a factory, but the main context is in Black Water by people utilizing Pharmaceuticals
- Various methods of Wastewater Treatment may concentrate these as well
- The Direct Impact is of concern, but synergistic effects are of special interest